Poryphin Synthesis, Degradation, Function Flashcards
describe the structure of functional porphyrin
4 pyrrole rings linked by methenyl bridges. conjugated double bonds throughout. metal ion sits in the middle.
roman numerals specify side chain symmetry. type III porphyrins are important in humans and have an asymmetric acetate/propionate side chain switch
give some examples of porphyrins
heme- iron
colbalt- cobalamine (vit b12)
chlorophyll- Mg
give some examples of heme proteins and what they do
mitochondrial cytochromes- generate H gradient required for ATP synthesis
hemoglobin/myoglobin- oxygen transport
cytochrome p450- metabolism of fat soluble cmpounds (formation of cholesterol and steroid metabolites). responsible for many drug interactions
catalase- antioxidant enzyme that hydrolyzes H2O2
cyanide poising
causes irreversible inhibition of mitochondrial cytochrome
describe heme biosynthesis
heme is made in the liver and bone marrow
ALA synthase catalyzes rxn of glycine and succinyl CoA to form ALA. This step is irreversible and rate limiting. inhibited by hemin and glucose
ALA dehydrase condenses 2 ALAs to form pyrrole compound PBG
Hydroxymethylbilane synthase condenses 4 molecules of PBG to form Hydroxymethylbilane. this is the second rate limiting step
uroporphyrinogen cosynthase closes the ring to form uroporphyrin I
uroporphyrinogen III cosynthase isomerizes D ring to form uroporphyrinogen III. this is the common precursor.
series of decarboxylation and oxidation rxns convert it to photoporphyrin IX- this glows whereas PBG and porphyrinogens are colorless
ferrochelatase introduces iron to form heme
what are the 4 major classes of disease associated w/ heme synthesis?
acute porphyrias, non acute porphyrias, lead poisoning, and iron deficiency anemia
describe acute porphyrias
autosomal dominant disorder that produce a blockade in rate limiting steps of heme pathway
acute intermittent porphyria
caused by deficiency of hydroxymethylbilane synthase- acute porphyria
symptoms are abdominal pain (increased ALA levels) and neuropsychiatric (ALA is structurally similar to GABA)
triggered by drug ingestion which consume heme, exacerbating the shortage. triggers an increase in ALA synthase and increase in ALA and BPG levels
diagnosed w/ excess PBG in urine, which will turn purple upon standing
treated w/ IV hemin and glucose
non acute porphyrias
primarily acquired via diseases associated w/ liver damage
blockade of heme formation occurs beyond hydroxymethylbilane formation, causing abnormal porphyrin derivatives to accumulate in liver and skin
ALA and hydroxymethylbilane synthase levels are normal- no neuro symptoms b/c ALA normal.
porphyria cutanea tarda
caused by reduced uroporphyrinogen decarboxylase, which accumulates uroporphyrins
treated w/ regular phlebotomy to remove excess porphyrin metabolites
pts should avoid alcohol and other liver toxins, excess sunlight
lead poisining
lead inhibits ALA dehydrase and ferrochelatase
symptoms are same as AIP plus anemia
iron-deficiency anemia
translation of eryhtoid ALA synthase mRNA is stimulated by iron in bone marrow. w/ a lack of iron, decrease in heme synthesis, causing anemia.
ALA synthase carries an iron response element, making it susceptible to iron levels
describe heme degradation
occurs in liver and spleen
heme is converted to biliverdin (green) by heme oxygenase and NADPH and O2
biliverdin reductase uses NADPH to reduce biliverdin to bilirubin (yellow-red)
albumin carries bilirubin to the liver.
bilirubin glucuronyltransferase conjugates 2 molecules of glucuronic acid to bilirubin to form bilirubin diglucuronide, which is water soluble and secreted in bile
in the intestine, bacteria reduce this to urobilinogen, which is colorless.
this is eventually oxidized to stercobilin, which is brown
some urobilinogen is reabsorbed into blood and transported to the kidney, converted into the yellow urobilin, and secreted
jaundice
skin and sclerae turn yellow
hemolytic- red cell lysis leading to increased unconjugated bilirubin
obstructive- blockage of bile ducts- increased conjugated bilirubin
hepatocellular- liver damage causes an increase in liver enzymes AST, ALT
neonatal- low levels of glucuronyltransferase- treated w/ blue flourescent light to catalyze coversion of bilirubin into water soluble metabolites
van den bergh rxn
biochemical assay that measures levels of conjugated and unconjugated bilirubin in the blood